Dr. Schoder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
New York, NY 10021Phone+1 212-639-7373- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Nuclear Medicine, 1998 - 2000
Humboldt University of Berlin - Charite Faculty of MedicineClass of 1989
Certifications & Licensure
NJ State Medical License 2006 - 2025
CA State Medical License 2000 - 2025
NY State Medical License 2000 - 2024- American Board of Nuclear Medicine Nuclear Medicine
- CBNCNuclear Cardiology
Clinical Trials
- Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors Start of enrollment: 2005 Jun 01
- The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules Start of enrollment: 2004 Mar 01
- The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer Start of enrollment: 2006 Apr 25
- Join now to see all
Publications & Presentations
PubMed
- F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.Samuel L Cytryn, Neeta Pandit-Taskar, Melissa A Lumish, Steven B Maron, Ping Gu, Geoffrey Y Ku, Joanne F Chou, Marinela Capanu, Ariel Antoine, Diane Loegel, Lara Feder...> ;Journal of Nuclear Medicine. 2024 Mar 21
- Patient metabolic profile defined by liver and muscleF-FDG PET avidity is independently associated with overall survival in gastric cancer.Vitiello, G., Gerardo A Vitiello, Vetri Sudar Jayaprakasam, Laura H Tang, Mark A Schattner, Yelena Y Janjigian, Geoffrey Y Ku, Steven B Maron, Heiko Schoder, Steven M ...> ;Gastric Cancer. 2024 May 1
- First-in-human imaging with [Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate.Tendler, S., Dunphy, M., Agee, M., O'Donoghue, J., Aly, R., Choudhury, N., Kesner, A., Kirov, A., Mauguen, A., Baine, M., Schoder, H., Weber, W., Rekhtman, N., Lyashch...> ;Medrxiv. 2024 Jan 11
- Join now to see all
Journal Articles
- CALBG 50604: Risk-Adapted Treatment of Non-Bulky Early Stage Hodgkin Lymphoma Based on Interim PETDavid J Straus, Heiko Schoder, Bruce D Cheson, John C Grecula, Lale Kostakoglu, Eric D Hsi, Leslie L Popplewell, John P Leonard, Craig H Moskowitz, Brad S Kahl, Jonath..., Blood
Abstracts/Posters
- A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin LymphomaHeiko Schoder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...Heiko Schoder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Long-Term Follow-up Confirms Durability of Single-Agent Brentuximab Vedotin As Pre-Transplant Salvage for Classical Hodgkin LymphomaHeiko Schoder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
The SNMMI and EANM Practice Guideline for Renal Scintigraphy in AdultsAugust 8th, 2018
Other Languages
- German
Hospital Affiliations
Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
